Ultrasonic rheology of a monoclonal antibody (IgG2) solution: Implications for physical stability of proteins in high concentration formulations
Atul Saluja
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269
Search for more papers by this authorAdvait V. Badkar
Global Biologics, Pfizer Global Research and Development, Chesterfield, Missouri 63017
Search for more papers by this authorDavid L. Zeng
Global Biologics, Pfizer Global Research and Development, Chesterfield, Missouri 63017
Search for more papers by this authorCorresponding Author
Devendra S. Kalonia
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269. Telephone: 860-486-3655; Fax: 860-486-4998Search for more papers by this authorAtul Saluja
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269
Search for more papers by this authorAdvait V. Badkar
Global Biologics, Pfizer Global Research and Development, Chesterfield, Missouri 63017
Search for more papers by this authorDavid L. Zeng
Global Biologics, Pfizer Global Research and Development, Chesterfield, Missouri 63017
Search for more papers by this authorCorresponding Author
Devendra S. Kalonia
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269. Telephone: 860-486-3655; Fax: 860-486-4998Search for more papers by this authorAbstract
The purpose of this work was to investigate if physical stability of a model monoclonal antibody (IgG2), as determined by extent of aggregation, was related to rheology of its solutions. Storage stability of the model protein was assessed at 25°C and 37°C for three months in solutions ranging from pH 4.0 to 9.0 and ionic strengths of 4 mM and 300 mM. The rheology of IgG2 solutions has been characterized at 25°C in our previous work and correlation of solution storage modulus (G′) with protein–protein interactions established. The extent of aggregation was consistent with solution rheology as understood in terms of changes in G′ with protein concentration. Thermodynamic stability of native IgG2 conformation increased with increasing pH. The correlation between rheology and aggregation was also assessed at increased ionic strengths. The decrease in aggregation was consistent with change in solution rheology profile at pH 7.4 and 9.0. The results provide evidence of a relationship between solution rheology and extent of aggregation for the model protein studied. The implications of this relationship for formulation and physical stability assessment in high concentration protein solutions are discussed. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 3181–3195, 2007
REFERENCES
- 1Shire SJ, Shahrokh Z, Liu J. 2004. Challenges in the development of high protein concentration formulations. J Pharm Sci 93: 1390–1402.
- 2Philo JS. 2003. Characterizing the aggregation and conformation of protein therapeutics. Am Biotechnol Lab 23: 22–24.
- 3Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharma Res 20: 1325–1336.
- 4Roberts CJ. 2003. Kinetics of irreversible protein aggregation: Analysis of extended lumry-eyring models and implications for predicting protein shelf life. J Phys Chem B 107: 1194–1207.
- 5Zettlmeissl G, Rudolph R, Jaenicke R. 1979. Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry 18: 5567–5571.
- 6Goldberg ME, Rudolph R, Jaenicke R. 1991. A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry 30: 2790–2797.
- 7Manning MC, Patel K, Borchardt RT. 1989. Stability of protein pharmaceuticals. Pharma Res 6: 903–918.
- 8Lumry R, Eyring H. 1954. Conformation changes of proteins. J Phys Chem 58: 110–120.
- 9Grillo AO, Edwards K-LT, Kashi RS, Shipley KM, Hu L, Besman MJ, Middaugh CR. 2001. Conformational origin of the aggregation of recombinant human factor VIII. Biochemistry 40: 586–595.
- 10Brems DN, Plaisted SM, Havel HA, Tomich CC. 1988. Stabilization of an associated folding intermediate of bovine growth hormone by site-directed mutagenesis. Proc Natl Acad Sci USA 85: 3367–3371.
- 11Kim YS, Wall JS, Meyer J, Murphy C, Randolph TW, Manning MC, Carpenter JF. 2000. Thermodynamic modulation of light chain amyloid fibril formation. J Biol Chem 275: 1570–1574.
- 12Meehan S, Berry Y, Luisi B, Dobson CM, Carver JA, MacPhee CE. 2004. Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem 279: 3413–3419.
- 13Stradner A, Thurston G, Lobaskin V, Schurtenberger P. 2004. Structure and interactions of lens proteins in dilute and concentrated solutions. Prog Colloid Polym Sci 126: 173–177.
- 14Harper JD, Lansbury PT. 1997. Models of amyloid seeding in alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385–407.
- 15Koo EH, Lansbury PT, Kelly JW. 1999. Amyloid diseases: Abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci USA 96: 9989–9990.
- 16Krishnan S, Chi EY, Webb JN, Chang BS, Shan D, Goldenberg M, Manning MC, Randolph TW, Carpenter JF. 2002. Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic Inhibition. Biochemistry 41: 6422–6431.
- 17Kendrick BS, Cleland JL, Lam XM, Nguyen T, Randolph TW, Manning MC, Carpenter JF. 1998. Aggregation of recombinant human interferon gamma: Kinetics and structural transitions. J Pharm Sci 87: 1069–1076.
- 18Brems DN, Plaisted SM, Kauffman EW, Havel HA. 1986. Characterization of an associated equilibrium folding intermediate of bovine growth hormone. Biochemistry 25: 6539–6543.
- 19Ikeguchi M, Kato S, Shimizu A, Sugai S. 1997. Molten globule state of equine beta-lactoglobulin. Proteins 27: 567–575.
10.1002/(SICI)1097-0134(199704)27:4<567::AID-PROT9>3.0.CO;2-7 CAS PubMed Web of Science® Google Scholar
- 20Webb JN, Webb SD, Cleland JL, Carpenter JF, Randolph TW. 2001. Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-gamma. Proc Natl Acad Sci USA 98: 7259–7264.
- 21Mulkerrin MG, Wetzel R. 1989. pH dependence of the reversible and irreversible thermal denaturation of gamma interferones. Biochemistry 28: 6556–6561.
- 22Lee JC, Timasheff SN. 1981. The stabilization of proteins by sucrose. J Biol Chem 256: 7193–7201.
- 23Arakawa T, Timasheff SN. 1982. Stabilization of protein structure by sugars. Biochemistry 21: 6536–6544.
- 24Kendrick BS, Li T, Chang BS. 2002. Physical stabilization of proteins in aqueous solutions. In: JF Carpenter, MC Manning, editors. Rational design of stable protein formulations: Theory and practice. New York: Kluwer Acaddmic/Plenum Publishers. p 203.
10.1007/978-1-4615-0557-0_3 Google Scholar
- 25Valente JJ, Payne RW, Manning MC, Wilson WW, Henry CS. 2005. Colloidal behavior of proteins: Effects of the second virial coefficient on solubility, crystallization and aggregation of proteins in aqueous solution. Curr Pharm Biotechnol 6: 427–436.
- 26Chi EY, Krishnan S, Kendrick BS, Chang BS, Carpenter JF, Randolph TW. 2003. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor. Protein Sci 12: 903–913.
- 27Saluja A, Badkar AV, Zeng DL, Nema S, Kalonia DS. 2007. Ultrasonic storage modulus as a novel parameter for analyzing protein-protein interactions in high protein concentration solutions: Correlation with static and dynamic light scattering measurements. Biophys J 92: 234–244.
- 28Saluja A, Kalonia DS. 2005. The application of ultrasonic shear rheometer to characterize rheological properties of high protein concentration solutions at microliter volume. J Pharm Sci 94: 1161–1168.
- 29Saluja A, Badkar AV, Zeng DL, Nema S, Kalonia DS. 2006. Application of high-frequency rheology measurements for analyzing protein-protein interactions in high protein concentration solutions using a model monoclonal antibody (IgG2). J Pharm Sci 95: 1967–1983.
- 30Harris RJ, Shire SJ, Winter C. 2004. Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies. Drug Dev Res 61: 137–154.
- 31Saluja A, Kalonia DS. 2004. Measurement of fluid viscosity at microliter volumes using quartz impedance analysis. AAPS Pharm Sci Tech 5: Article 47.
- 32Davis-Searles PR, Saunders AJ, Erie DA, Winzor DJ, Pielak GJ. 2001. Interpreting the effects of small uncharged solutes on protein-folding equilibria. Annu Rev Biophys Biomol Struct 30: 271–306.
- 33George A, Wilson WW. 1994. Predicting protein crystallization from a dilute solution property. Acta Crystallogr D Biol Crystallogr D50: 361–365.
- 34Jiskoot W, Beuvery EC, De Koning AAM, Herron JN, Crommelin DJA. 1990. Analytical approaches to the study of monoclonal antibody stability. Pharma Res 7: 1234–1241.
- 35Kanapuram SR. 2000. The effect of solution environment on the conformational stability and aggregation of monoclonal antibody OKT-4. Storres: Department of Pharmaceutical Sciences, University of Connecticut. p 171.
- 36Lakowicz JR. 1999. Principles of Fluorescence Spectroscopy. New York: Plenum Publishing Corporation. p 698.
- 37Sharma VK, Kalonia DS. 2003. Temperature- and pH-induced multiple partially unfolded states of recombinant human interferon-a2a: Possible implications in protein stability. Pharma Res 20: 1721–1729.
- 38Donovan JW, Ross KD. 1973. Increase in the stability of avidin produced by binding of biotin. A differential scanning calorimetric study of denaturation by heat Biochemistry 12: 512–517.
- 39Relkin P. 1994. Differential scanning calorimetry: A useful tool for studying protein denaturation. Thermochim Acta 246: 371–386.
- 40Ho JGS, Middelberg APJ, Ramage P, Kocher HP. 2003. The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient. Protein Sci 12: 708–716.
- 41Ross PD, Minton AP. 1977. Analysis of non-ideal behavior in concentrated hemoglobin solutions. J Mol Biol 112: 437–452.
- 42Chen B, Bautista R, Yu K, Zapata GA, Mulkerrin MG, Chamow SM. 2003. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Pharma Res 20: 1952–1960.
- 43Relton JM. 2001. Concentrated antibody preparation. ed.: Pat No WO9745140.
- 44Yang JT. 1961. The viscosity of macromolecules in relation to molecular conformations. Adv Protein Chem 16: 323–401.
- 45Liu J, Shire SJ. 2002. Reduced-viscosity concentrated protein formulations. ed.: Pat No WO0230463.
- 46Liu J, Nguyen MDH, Andya JD, Shire SJ. 2005. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. J Pharm Sci 94: 1928–1940.
- 47Senderoff RI, Kontor KM, Kreilgaard L, Chang JJ, Patel S, Krakover J, Heffernan JK, Snell LB, Rosenberg GB. 1998. Consideration of conformational transitions and racemization during process development of recombinant glucagon-like peptide-1 (rGLP-1). J Pharm Sci 87: 183–189.